Pierre Ménétrier and his disease
- PMID: 23303980
- PMCID: PMC3540591
Pierre Ménétrier and his disease
Abstract
In 1888, Pierre Ménétrier first described the disease that bears his name. Many of the findings he reported then remain accepted features of the disease. Based on studies performed in our laboratory over the past 20 years, we have implicated increased transforming growth factor-α (TGFα) expression and heightened epidermal growth factor receptor (EGFR) activity in the pathogenesis of Ménétrier's disease. Herein, we provide a historical perspective of this rare disorder, review our experience with Ménétrier's disease, and discuss future challenges and opportunities posed by this disorder.
Conflict of interest statement
Potential Conflicts of Interest: None disclosed.
Figures
References
-
- Menetrier P. Des polyadenomes gastriques et leur rapport avecle cancer de l'estomac. Arch Physiol Norm Pathol. 1888;1:32–55. 236–62.
-
- Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 1993;104:1310–9. - PubMed
-
- Coffey RJ, Jr, Derynck R, Wilcox JN, et al. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature. 1987;328:817–20. - PubMed
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous